
Latest news, updates, and announcements from Converge Bio.

Converge Bio secured $25 million in Series A funding led by Bessemer Venture Partners to scale its generative AI for drug discovery. By training models on molecular data rather than text, the platform...

Converge Bio raised 25 million dollars in Series A funding led by Bessemer, bringing its total financing to 30 million dollars. 🚀 The platform has completed 40 programs, achieving 4 to 7 times higher...
Converge Bio secured 25 million USD in Series A funding led by Bessemer Venture Partners to scale its generative AI platform for biological data. Backed by Meta and OpenAI executives, the startup has...